Focus Stocks
GlaxoSmithKline Close to Important Technical Levels
Published on Friday, 10 February 2012 06:36 Written by TradersHuddle Wire
New York, February 10th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) closed the trading session at $45.06 near its 50 day and 200 day moving averages currently set at $44.92 and $43.29 respectively. GlaxoSmithKline's price action is above these important levels, which could translate into a trading opportunity.
GlaxoSmithKline plc (NYSE:GSK) is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. Its over the counter medicines and health related consumer products are marketed under brand names like Panadol, Nicorette, Breathe Right, Tums, Aquafresh, and Sensodyne among others.
Although the price action is above important moving averages, it's important to highlight that the 50 day moving average is currently above the 200 day moving average, signaling that the stock is not technically broken from the long side and buying the dip strategy might be the best setup out there.
Looking at peaks and troughs horizontal support and resistance levels, we can see current calculated support at $43.72 and calculated resistance at $44.65. These levels should also be evaluated by traders when planning their trades, as they provide an insight into the latest price action.
If traders want to establish a position on GlaxoSmithKline need to place special attention to the stock price action and establish a position as close to the moving averages as possible. Also traders need to consider the latest price action, via the stocks current range defined by the peaks and troughs algorithm, not forgetting that if the stock had a wild move outside its range, it would certianly take a few days to establish support and resistance.
Related Articles
- Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
- Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim® in the U.S.
- Trading Idea: Is GlaxoSmithKline close to Support?
- Close to Key Levels: GlaxoSmithKline
- Trading Idea: Key levels for GlaxoSmithKline
- GlaxoSmithKline Is Near its 50 Day Moving Average
- Stock Futures Lower amid Greek Chaos. Stocks to Watch: AAPL, BAC, CSCO, GSK, M, NEM, TM, DIS
- Is GlaxoSmithKline Closing in to Resistance?
- GlaxoSmithKline Is Near its 50 Day Moving Average
- GlaxoSmithKline Is Near Resistance
Related Partner Headlines
- Bankia Customers Withdraw 1B Euros in One Week: Hot Trends - TheStreet.com
- Pfizer, Glaxo, J&J Grab ASCO Spotlight - TheStreet.com
- GlaxoSmithKline Buys Back 1.35M Shares - Benzinga
- Glaxo's Bid for Human Genome Turns Hostile: Hot Trends - TheStreet.com
- GlaxoSmithKline Stock To Go Ex-dividend Tomorrow (GSK) - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- GlaxoSmithKline Stock Hits New 52-Week High (GSK) - TheStreet.com
- Human Genome Rejects $2.6B Bid From GlaxoSmithKline - TheStreet.com
- GlaxoSmithKline Boosts Stake in Theravance - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
CHS/Community Health Systems, Inc. Announces Completion of Exchange Offer for Its 8.00% Senior Notes Due 2019 -
InvenSense® Kicks off First Annual Motion Interface Developers Conference -
Tech Data Corporation to Host Annual Meeting of Shareholders on May 30, 2012 -
Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes -
Winthrop Realty Trust Announces Resignation of Chief Financial Officer Effective June 15, 2012 -
Hot Topics Recap: London Olympics/Summer Games -
Business Users of Macs Can Now Make Remote Deposits to Wells Fargo with Panini Scanners -
Landauer, Inc. Declares Regular Cash Dividend









